I think they white label Westpac's online banking but are well behind latest Westpac's IOLB updates? Might be wrong on that, happy to be corrected?
Printable View
HGH share price heading to Forbar's target pretty fast ...and getting further away from that pie in the sky Jarden target
Maybe, just maybe, Forbar called it better than Jarden
I know someone is going to ask me what I think about HGH on Sunday so here's how the situation is as of yesterday's closing price.
FY21 PE's (average of analysts views off market screener as of yesterday's closing price).
Peer Group
NAB 16.4
WBC 14.9
CBA 17.0
BEN 13.8
BOQ 16.1
ANZ 14.3
Average 15.4
HGH FY21 PE 12.5
I think HGH can grow its eps at least as well as its peer group in the years ahead and is well positioned to encapsulate that growth from a recovering economy benifiting from the gradual opening up as the vaccine gets rolled out. 12.5 marks out HGH as a very good value growth stock.
I'm expecting about 11 cps in dividends for FY22 as the RBNZ withdraw dividend restrictions and its the only bank to offer full imputation credits.
11 / 0.72 = 15.28 cps gross and on this morning's share price of $1.79 that's a forecast FY22 gross yield of 8.5%
I have noticed a lot more TV advertising in the past couple of weeks for HGH mortgages, both for reverse mortgage product and the new online platform for regular mortgages.
What’s up ...Hgh share price back in the 170’s
What was Forbar’s target again?
Last update $1.72. Maybe they not so dope after all.
https://www.marketscreener.com/quote...144/consensus/
Rated outperform. Average target price of 4 analysts is $1.94
Average expected eps for FY21 = 14 cps and for FY22 15 cps. Trading on just 11.9 times FY22 average broker earnings. Hmmm